Masataka Nishiga
Cardiovascular Institute of the South(US)Stanford University(US)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cardiac Valve Diseases and Treatments, Cancer-related molecular mechanisms research, Cardiac Fibrosis and Remodeling, Circular RNAs in diseases
Most-Cited Works
- → COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives(2020)1,455 cited
- → MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice(2013)225 cited
- → MicroRNA-451 Exacerbates Lipotoxicity in Cardiac Myocytes and High-Fat Diet-Induced Cardiac Hypertrophy in Mice Through Suppression of the LKB1/AMPK Pathway(2014)208 cited
- → An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium(2019)139 cited
- → Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation(2022)122 cited
- → Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways(2017)82 cited
- → MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol(2016)69 cited
- → The use of new CRISPR tools in cardiovascular research and medicine(2022)57 cited
- → Progression of Isolated Tricuspid Regurgitation Late After Left-Sided Valve Surgery - Clinical Features and Mechanisms -(2011)50 cited
- → MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo(2014)49 cited